Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers-Reference-Cited by-同舟云学术

Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers

Published:2023-03 Issue:3 Volume:41 Page:145.e7-145.e15
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Kwon Daniel H.^ORCID,Shakhnazaryan Nonna,Shui David,Hong Julian C.,Mohamad Osama,de Kouchkovsky Ivan,Borno Hala T.,Bose Rohit,Chou Jonathan,Desai Arpita,Fong Lawrence,Friedlander Terence W.,Koshkin Vadim S.,Aggarwal Rahul R.,Feng Felix Y.,Hope Thomas A.,Small Eric J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference19 articles.

1. Trends in incidence of metastatic prostate cancer in the US;Desai;JAMA Netw Open,2022

2. Quality of life in prostate cancer patients taking androgen deprivation therapy;Dacal;J Am Geriatr Soc,2006

3. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial;Phillips;JAMA Oncol,2020

4. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018

5. Radiotherapy of oligometastatic prostate cancer: a systematic review;Rogowski;Radiat Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience;Medicina;2023-08-09